• Tue news: Merck's Keytruda stages comeback in head and neck cancer. GSK, Pfizer RSV vaccine sales fall. Astellas gene therapy bet. Extreme weather —>drug shortages. J&J discontinues bladder cancer drug. See more on our front page

This ain't the Deep State

You don't know anything about investing and nobody cares or even knows what in the hell you are talking about. Shoot you and E tomorrow? TLRY BYMD? Why don't you try just spelling out the name of the companies? Nobody cares enough to look these companies up and nobody believes for a second that you have any investment experience. Maybe a pot stock perhaps, but that's about it.
Vag knows WAAAYYYY more than me on investing, so I will defer to him. Now, if Anonotwat has posted this, my reaction would have been similar to yours.